Optimizing research to speed up availability of pediatric antiretroviral drugs and formulations
M Penazzato, D Gnanashanmugam… - Clinical Infectious …, 2017 - academic.oup.com
Globally 1.8 million children are living with human immunodeficiency virus (HIV), yet only
51% of those eligible actually start treatment. Research and development (R&D) for pediatric …
51% of those eligible actually start treatment. Research and development (R&D) for pediatric …
Optimizing clinical trial design to maximize evidence generation in pediatric HIV
D Ford, R Turner, A Turkova, M Penazzato… - JAIDS Journal of …, 2018 - journals.lww.com
For HIV-infected children, formulation development, pharmacokinetic (PK) data, and
evaluation of early toxicity are critical for licensing new antiretroviral drugs; direct evidence …
evaluation of early toxicity are critical for licensing new antiretroviral drugs; direct evidence …
Perinatal antiretroviral intensification to prevent intrapartum HIV transmission when antenatal antiretroviral therapy is initiated less than 8 weeks before delivery
M Lallemant, B Amzal, P Sripan, S Urien… - JAIDS Journal of …, 2020 - journals.lww.com
Methods: In this single-arm Bayesian trial, pregnant women with HIV receiving standard of
care antiretroviral prophylaxis in Thailand (maternal antenatal lopinavir-based cART; …
care antiretroviral prophylaxis in Thailand (maternal antenatal lopinavir-based cART; …
[HTML][HTML] Joint treatment with azidothymidine and antiserum for eradication of avian leukosis virus subgroup a contamination in vaccine virus seeds
S Cui, Y Li, Y Wang, Z Cui, S Chang, P Zhao - Poultry science, 2019 - Elsevier
Contamination of avian attenuated vaccines by avian leukosis virus (ALV) is considered to
be a specific horizontal transmission of ALV. Eradication of ALV contamination in vaccine …
be a specific horizontal transmission of ALV. Eradication of ALV contamination in vaccine …
Prevención de la transmisión vertical del VIH: indicaciones para el manejo de gestantes seropositivas
R González Meijueiro - minerva.usc.es
Introducción: el VIH es un retrovirus que se transmite a través de fluidos corporales y que
ataca a distintas células, especialmente los linfocitos T-CD4, provocando un estado de …
ataca a distintas células, especialmente los linfocitos T-CD4, provocando un estado de …
[PDF][PDF] Optimising research to speed up availability of paediatric antiretroviral drugs and formulations
MD Martina Penazzato - core.ac.uk
Globally 1.8 million children are estimated to be living with HIV, yet only 51% of those
eligible actually start treatment. The completion of research and development (R&D) for …
eligible actually start treatment. The completion of research and development (R&D) for …